Cycloastragenol, a triterpene aglycone derived from Radix astragali, suppresses the accumulation of cytoplasmic lipid droplet in 3T3-L1 adipocytes

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 306-311

  Wang, Shifeng ^a   Zhai, Chenxi ^a   Liu, Qing ^a   Wang, Xing ^a   Ren, Zhenzhen ^a   Zhang, Yuxin ^a   Zhang, Yanling ^a   Wu, Qinghua ^b   Sun, Shengnan ^b   Li, Shiyou ^c   Qiao, Yanjiang ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b HD Biosciences Co Ltd   (China)

^c Chinese Academy of Sciences   (China)

Author keywords

3T3 L1 adipocyte; Adipogenesis; Calcium mobilization; Cycloastragenol; Radix astragali

Indexed keywords

AGLYCONE; ANTIOBESITY AGENT; ASTRAGALOSIDE IV; CALCIUM ION; CYCLOASTRAGENOL; FAT DROPLET; GLUTATHIONE; MEVINOLIN; REACTIVE OXYGEN METABOLITE; TRITERPENE; UNCLASSIFIED DRUG;

3T3 CELL LINE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; ASTRAGALUS PLANT; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM MOBILIZATION ASSAY; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG CYTOTOXICITY; DRUG MECHANISM; HEPG2 CELL LINE; HYPERLIPIDEMIA; IC 50; LIPID STORAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE;

3T3-L1 ADIPOCYTE; ADIPOGENESIS; CALCIUM MOBILIZATION; CYCLOASTRAGENOL; RADIX ASTRAGALI;

3T3 CELLS; ADIPOCYTES; ANIMALS; ASTRAGALUS PLANT; CALCIUM; CYTOPLASM; DRUGS, CHINESE HERBAL; LIPID METABOLISM; MICE; SAPOGENINS;

EID: 84904759101     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.05.117     Document Type: Article

References (37)

1. N. Krahmer, R.V. Farese Jr., and T.C. Walther Balancing the fat: lipid droplets and human disease EMBO Mol. Med. 5 2013 905 915
2. B. Klop, J.W. Elte, and M.C. Cabezas Dyslipidemia in obesity: mechanisms and potential targets Nutrients 5 2013 1218 1240
3. P.G. Kopelman Obesity as a medical problem Nature 404 2000 635 643
4. K.E. Corey, and L.M. Kaplan Obesity and liver disease: the epidemic of the twenty-first century Clin. Liver Dis. 18 2014 1 18
5. M. Dragunow, R. Cameron, P. Narayan, and S. O'Carroll Image-based high-throughput quantification of cellular fat accumulation J. Biomol. Screen. 12 2013 999 1005
6. F.M. Gregoire, C.M. Smas, and H.S. Sul Understanding adipocyte differentiation Physiol. Rev. 78 1998 783 809
7. T. Hashimoto, T. Yokokawa, Y. Endo, N. Iwanaka, K. Higashida, and S. Taguchi Modest hypoxia significantly reduces triglyceride content and lipid droplet size in 3T3-L1 adipocytes Biochem. Biophy. Res. Commun. 440 2013 43 49
8. H. Shi, Y.D. Halvorsen, P.N. Ellis, W.O. Wilkison, and M.B. Zemel Role of intracellular calcium in human adipocyte differentiation Physiol. Genomics 3 2000 75 82
9. B. Jensen, M.C. Farach-Carson, E. Kenaley, and K.A. Akanbi High extracellular calcium attenuates adipogenesis in 3T3-L1 preadipocytes Exp. Cell Res. 301 2004 280 292
10. 2+ in the early stages of murine adipocyte differentiation as evidenced by calcium mobilizing agents Differentiation 60 1996 151 158
11. S.R. Fauce, B.D. Jamieson, A.C. Chin, R.T. Mitsuyasu, S.T. Parish, and H.L. Ng et al. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes J. Immunol. 181 2008 7400 7406
12. T.M. Rickabaugh, and B.D. Jamieson A challenge for the future: aging and HIV infection Immunol. Res. 48 2010 59 71
13. J. Zhao, H. Zhu, S. Wang, X. Ma, X. Liu, and C. Wang et al. Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritric cells in LDL receptor knockout mice fed a high-fat diet Curr. Pharm. Des. 19 2013 5891 5896
14. J. Zhu, S. Lee, M.K. Ho, Y. Hu, H. Pang, and F.C. Lp et al. In vitro intestinal absorption and first-pass intestinal and hepatic metabolism of cycloastragenol, a potent small molecule telomerase activator Drug Metab. Pharmacokinet. 25 2010 477 486
15. J. Yang, H.X. Wang, Y.J. Zhang, Y.H. Yang, M.L. Lu, and J. Zhang et al. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-kB signaling pathway in isoproterenol-induced myocardial hypertrophy J. Ethnopharmacol. 150 2013 1062 1070
16. D.Y. Lee, H.J. Noh, J. Choi, K.H. Lee, M.H. Lee, and J.H. Lee et al. Anti-inflammatory cycloartane-type saponins of Astragalus membranaceus Molecules 18 2013 3725 3732
17. L.Y. Yung, W.S. Lam, M.K. Ho, Y. Hu, F.C. Lp, and H. Pang et al. Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types Planta Med. 78 2012 115 121
18. K. Zebisch, V. Voigt, M. Wabitsch, and M. Brandsch Protocol for effective differentiation of 3T3-L1 cells to adipocytes Anal. Biochem. 425 2012 88 90
19. P. Greenspan, E.P. Mayer, and S.D. Fowler Nile red: a selective fluorescent stain for intracellular lipid droplets J. Cell Biol. 100 1985 965 973
20. 1 antagonist for the treatment of cardiovascular disease Planta Med. 79 2013 322 326
21. J.A. Tobert Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors Nat. Rev. Drug Discov. 2 2003 517 526
22. L. Mališová, Z. Kováčová, M. Koc, J. Kračmerová, V. Stich, and L. Rossmeislová Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes PLoS ONE 8 2013 1 11
23. W. Guo, K.M. Zhang, K. Tu, Y.X. Li, L. Zhu, and H.S. Xiao et al. Adipogenesis licensing and execution are disparately linked to cell proliferation Cell Res. 19 2009 216 223
24. L. Tolosa, S. Pinto, M.T. Donata, A. Lahoz, J.V. Castell, and J.E. O'Connor et al. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs Toxicol. Sci. 127 2012 187 198
25. D. Wu, and Al. Cederbaum Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1 Alcohol. Clin. Exp. Res. 25 2001 619 628
26. R. Heidari, H. Babaei, and M.A. Eghbal Cytoprotective effects of organosulfur compounds against methimazole induced toxicity in isolated rat hepatocytes Adv. Pharm. Bull. 3 2013 135 141
27. A. Liu, S. Xie, H. Sun, F.J. Gonzalez, X. Wei, and R. Dai Myotoxicity of gemfibrozil in cynomolgus monkey model and its relationship to pharmacokinetic properties Toxicol. Appl. Pharmacol. 235 2009 287 295
28. P. Domínguez Tordera, J.F. Comellas Alabern, J.F. Comellas Alabern, and F. Ronda Rivero Gemfibrozil hepatotoxicity: a case report Int. J. Clin. Pharm. 33 2011 730 732
29. N.J. Szabo Dietary safety of cycloastragenol from Astragalus spp.: subchronic toxicity and genotoxicity studies Food Chem. Toxicol. 64 2014 322 334
30. M. Bishnoi, K.K. Kondepudi, A. Gupta, A. Karmase, and R.K. Boparai Expression of multiple transient receptor potential channel genes in murine 3T3-L1 cell lines and adipose tissue Pharmacol. Rep. 65 2013 751 755
31. L.L. Zhang, D. Yan Liu, L.Q. Ma, Z.D. Luo, and T.B. Cao et al. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity Circ. Res. 100 2007 1063 1070
32. L.H. Ma, Y. Deng, B. Zhang, Y.Q. Bai, J. Cao, and S.Y. Li et al. Pinacidil, a Katp channel opener, identified as a novel agonist for TRPA1 Chin. Sci. Bull. 57 2012 1810 1817
33. 2+ signaling Cold Spring Harb. Perspect Biol. 2 2010 1 31
34. 2+ signaling Cell Calcium 40 2006 261 275
35. K.H. Chen, X.H. Xu, Y. Liu, Y. Hu, M.W. Jin, and G.R. Li TRPM7 channels regulate proliferation and adipogenesis in 3T3-L1 preadipocytes J. Cell. Physiol. 229 2014 60 67
36. Ö. Kaplan, M. NazIroǧlu, M. Güney, and M. Aykur Non-steroidal anti-inflammatory drug modulates oxidative stress and calcium ion levels in the neutrophils of patients with primary dysmenorrhea J. Reprod. Immunol. 100 2013 87 92
37. E. Szabo, Y. Qiu, S. Baksh, M. Michalak, and O. Michal Calreticulin inhibits commitment to adipocyte differentiation J. Cell Biol. 182 2008 103 116